Whitehawk Therapeutics (WHWK) Gains from Investment Securities (2015 - 2025)
Whitehawk Therapeutics (WHWK) reported Gains from Investment Securities of $683897.0 for Q2 2025, up 699.91% on a QoQ basis from -$114000.0 in Q1 2025.
Whitehawk Therapeutics (WHWK) has 11 years of Gains from Investment Securities data on file, last reported at $683897.0 in Q2 2025.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $683897.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$114000.0 (up 56.98% YoY) and the FY2025 annual result came in at $8.1 million, up 64.05% from the prior year.
- Gains from Investment Securities grew to $683897.0 in Q2 2025 per WHWK's latest filing, from -$114000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.3 million in Q3 2021 and bottomed at -$1.6 million in Q4 2022.
- The 5-year median for Gains from Investment Securities is -$118000.0 (2023), against an average of $59467.9.
- The widest annual swing landed in 2021, when Gains from Investment Securities surged 2343.86%; it then tumbled 218.66% in 2023.
- Tracing WHWK's Gains from Investment Securities over 5 years: stood at $1.3 million in 2021, then plunged by 226.84% to -$1.6 million in 2022, then surged by 92.71% to -$120000.0 in 2023, then retreated by 25.83% to -$151000.0 in 2024, then surged by 552.91% to $683897.0 in 2025.
- Per Business Quant, the three latest WHWK Gains from Investment Securities figures stand at $683897.0 (Q2 2025), -$114000.0 (Q1 2025), and -$151000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 683,897.00 |
| Jun 30, 2025 | 683,897.00 |
| Mar 31, 2025 | -114,000.00 |
| Mar 31, 2025 | -114,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Dec 31, 2023 | -120,000.00 |
| Dec 31, 2023 | -120,000.00 |
| Sep 30, 2023 | -123,000.00 |
| Sep 30, 2023 | -123,000.00 |
| Jun 30, 2023 | -159,000.00 |
| Jun 30, 2023 | -159,000.00 |
| Mar 31, 2023 | -116,000.00 |
| Mar 31, 2023 | -116,000.00 |
| Dec 31, 2022 | -1.65 Mn |
| Dec 31, 2022 | -1.65 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 134,000.00 |
| Jun 30, 2022 | 134,000.00 |
| Mar 31, 2022 | -125,000.00 |
| Mar 31, 2022 | -125,000.00 |
| Sep 30, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Jun 30, 2021 | 208,208.00 |
| Jun 30, 2021 | 208,208.00 |
| Dec 31, 2020 | 390,949.00 |
| Dec 31, 2020 | 390,949.00 |
| Sep 30, 2020 | 53,131.00 |
| Sep 30, 2020 | 53,131.00 |
| Jun 30, 2020 | 260,720.00 |
| Jun 30, 2020 | 260,720.00 |
| Mar 31, 2020 | 702,000.00 |
| Mar 31, 2020 | 702,000.00 |
| Dec 31, 2019 | 2.68 Mn |
| Dec 31, 2019 | 2.68 Mn |
| Jun 30, 2019 | 2.80 Mn |
| Jun 30, 2019 | 2.80 Mn |
| Mar 31, 2019 | 1.82 Mn |
| Mar 31, 2019 | 1.82 Mn |
| Dec 31, 2018 | 3.35 Mn |
| Dec 31, 2018 | 3.35 Mn |
| Sep 30, 2018 | 97,500.00 |
| Sep 30, 2018 | 97,500.00 |
| Jun 30, 2018 | 1.52 Mn |
| Jun 30, 2018 | 1.52 Mn |
| Mar 31, 2018 | 871.00 |
| Mar 31, 2018 | 871.00 |
| Dec 31, 2017 | 1.91 Mn |
| Dec 31, 2017 | 1.91 Mn |
| Mar 31, 2017 | 924,706.00 |
| Mar 31, 2017 | 924,706.00 |
| Dec 31, 2016 | 927,592.00 |
| Dec 31, 2016 | 927,592.00 |
| Sep 30, 2016 | 50,228.00 |
| Sep 30, 2016 | 50,228.00 |
| Jun 30, 2016 | 50,228.00 |
| Jun 30, 2016 | 50,228.00 |
| Dec 31, 2015 | 907,485.00 |
| Dec 31, 2015 | 907,485.00 |